ea0089c35 | Clinical – Surgery/Applied Pathology | NANETS2022
Limbach, MD Kristen E.
, Mahuron, MD Kelly M.
, Ituarte, PhD Philip H. G.
, Kessler, MD Jonathan
, Li, MD Daneng
, Singh, MD Gagandeep
Background: Bone metastasis from gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) was once considered rare, but prevalence has recently been reported as high as 12%. Although bone metastasis has been associated with poor prognosis, the most frequent cause of mortality in this population remains liver failure when liver metastases are present. Thus, it remains unclear whether patients with concurrent liver and bone metastasis who receive liver directed therapy (LDT) w...